Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSteppe Cement Regulatory News (STCM)

Share Price Information for Steppe Cement (STCM)

Share Price is delayed by 15 minutes
Get Live Data
19.50    0.00 (0.00%)
Bid:
19.00
Ask:
20.00
Spread: 1.00 (5.263%)
Market Cap: £42.70m
STCM Live PriceLast checked at - London Stock Exchange

Intraday Steppe Cement Share Chart

Market Update for 3Q 2012

12 Oct 2012 07:00

RNS Number : 5651O
Steppe Cement Limited
12 October 2012
Β 

ο»Ώ

Steppe Cement Ltd

12 October 2012

Β 

Market Update for the Third Quarter ended 30 September 2012

Β 

Third quarter 2012 revenue of KZT 7,233 million was 28% higher than the corresponding quarter in 2011. For the 9 months ended 30 September 2012, Steppe Cement Ltd ("Steppe Cement" or "the Company") recorded revenue of KZT 14,961 million compared with KZT 11,933 million in the corresponding 9 month period in 2011, representing a 25% improvement.

Β 

Sales volume of 518,433 tonnes was achieved during the third quarter, a 16% increase over the third quarter of 2011. For the first 9 months of 2012, the sales volume increased by 8% to 1,134,271 tonnes from 1,048,122 tonnes in the corresponding 9 month period in 2011.

Β 

Average price (ex-VAT) for delivered cement was 16% higher at KZT 13,190 per tonne in the first 9 months this year compared with KZT 11,385 per tonne in the corresponding period in 2011. For the 9 months to September 2012, the ex-factory price stood at KZT 11,119 per tonne representing USD74 per tonne based on current exchange rates.Β 

Β 

For the first 9 months of 2012, the cement market in Kazakhstan increased by 13% compared to the corresponding period in 2011. Steppe Cement has therefore revised its estimate of the cement market consumption for 2012 from 6.8 million tonnes to 7.0 million tonnes. Imports into Kazakhstan declined to 13% from 15% in the corresponding 9-month period in 2011. Steppe Cement's market share at 20% is similar compared with the corresponding 9-month period in 2011.

Β 

Line 5 update

Β 

In the first 9 months of 2012, Steppe Cement has spent approximately USD 6 million towards the completion of line 5 out of its cash flow. The Company continues to explore different options to fund the remaining USD 34 million including debt, internally generated cash flow and equity.

Β 

Central Asia Cement, a fully owned subsidiary of the Company, has registered two bonds with 5 and 6 year maturities with the Committee for the Control and Supervision of the Financial Market and Financial Organisations of the National Bank of the Republic of Kazakhstan (FMSC). We are proceeding to obtain a listing for these in the Kazakhstan Stock Exchange (KASE). The decision on final bond placement and its amount will depend on the yield that can be obtained. In parallel we have obtained preliminary terms from multilateral organizations.

Β 

The board intends to choose among the different sources of financing before the end of 2012 with a completion target for the project in the last quarter of 2013.

Β 

Β 

The Company's Nominated Adviser is RFC Ambrian Limited.

Contact: Stephen Allen or Trinity McIntyre, ph: +61 8 9480 2500

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCBKBDNQBDKBKD
Date   Source Headline
10th Jul 20197:00 amRNSMarket Update for the First Half of 2019
20th Jun 20199:41 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSFinal Dividend FY2018
13th Jun 20197:00 amRNSAGM Results
15th May 20197:00 amRNSAnnual Report 2018 and Notice of AGM
15th May 20197:00 amRNSCEO Statement 2018
23rd Apr 20197:00 amRNSHoldings in Company
10th Apr 20197:00 amRNSMarket update for the quarter ended 31 March 2019
4th Mar 20194:35 pmRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSHoldings in Company
10th Jan 20197:00 amRNSPreliminary Update for Year ended 31 December 2018
23rd Oct 20187:00 amRNSChange in Substantial Shareholders' Interests
8th Oct 20187:21 amRNSMarket Update for 3Q ended 30 September 2018
18th Sep 20187:00 amRNSInterim Results
13th Jul 20187:00 amRNSHolding(s) in Company
11th Jul 20187:00 amRNSMarket update for first half of 2018
25th Jun 20187:00 amRNSHolding(s) in Company
19th Jun 20187:00 amRNSDividend Announcement
15th Jun 20187:00 amRNSAGM Results
29th May 20187:00 amRNSAnnual Report 2017 and Notice of AGM
29th May 20187:00 amRNSResults and Annual Report 2017
12th Apr 20187:00 amRNSMarket update for the quarter ended 31 March 2018
15th Jan 20187:00 amRNSPreliminary Update for Year Ended 31 December 2017
8th Dec 20177:00 amRNSNew Significant Shareholder
17th Nov 20177:00 amRNSRepayment of Bonds
12th Oct 20177:00 amRNSAppointment of Independent Non-Executive Director
11th Oct 20177:00 amRNSMarket update for 3Q ended 30 September 2017
13th Sep 20177:00 amRNSInterim Results
15th Jun 20177:00 amRNSAGM Results
23rd May 20177:00 amRNSAnnual Report 2016
22nd May 20177:00 amRNSResults and Annual Report for 2016
13th Apr 20177:00 amRNSMarket update for March quarter
13th Jan 20177:00 amRNSPreliminary Update for Year Ended 31 December 2016
20th Dec 20167:00 amRNSHoldings in Company
29th Nov 20168:33 amRNSRefinancing and extension of loans
15th Nov 20167:00 amRNSPurchase of Shares by Substantial Shareholder
18th Oct 20167:00 amRNSHoldings in Company
12th Oct 20167:00 amRNSMarket Update for 3Q 2016
13th Sep 201612:39 pmRNSInterim Results - Correction
13th Sep 20167:00 amRNSInterim Results
8th Aug 20167:00 amRNSHoldings in Company
19th Jul 20168:23 amRNSHoldings in Company
14th Jul 20167:00 amRNSMarket update for the first half of 2016
10th Jun 20169:41 amRNSResult of AGM
26th May 20167:00 amRNSAnnual Report 2015
25th May 20167:00 amRNSResults and Annual Report for 2015
14th Apr 20167:00 amRNSMarket update for quarter to 31 March 2016
14th Jan 20167:00 amRNSPreliminary update to 31 December 2015
14th Dec 20157:00 amRNSChange in significant shareholding
26th Nov 20157:00 amRNSChange in substantial shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.